Business · 21/08/2019Updated: 10/17/2026 · 1 min read
Psychopharmacologic Drugs Advisory Committee Meeting Canceled Due to New Information
Summary
The Psychopharmacologic Drugs Advisory Committee meeting originally scheduled for July 31, 2019, has been canceled, following a notice published in the Federal Register on June 14, 2019, due to new information regarding the application under review.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →